Skip Content
You are currently on the new version of our website. Access the old version .

116 Results Found

  • Article
  • Open Access
16 Citations
9,125 Views
12 Pages

Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays

  • Jodi Hagen,
  • Ryan Zimmerman,
  • Christine Goetz,
  • Jody Bonnevier,
  • Jeffrey P. Houchins,
  • Kevin Reagan and
  • Alexander E. Kalyuzhny

11 February 2015

ELISPOT, ELISA and flow cytometry techniques are often used to study the function of immune system cells. It is tempting to speculate that these assays can be used interchangeably, providing similar information about the cytokine secreting activity o...

  • Protocol
  • Open Access
2 Citations
1,868 Views
14 Pages

Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity

  • Yinyi Yu,
  • Krystal Meza,
  • Chase Colbert,
  • Daniel F. Hoft,
  • Anna Jaunarajs,
  • Azra Blazevic,
  • Sharon E. Frey and
  • Getahun Abate

31 December 2024

Background: Available assays to measure pox virus neutralizing antibody titers are laborious and take up to 5 days. In addition, assays to measure T cell responses require the use of specific antigens, which may not be the same for all pox viruses. T...

  • Article
  • Open Access
4 Citations
3,880 Views
14 Pages

Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation

  • Eva Wagner-Drouet,
  • Daniel Teschner,
  • Christine Wolschke,
  • Kerstin Schäfer-Eckart,
  • Johannes Gärtner,
  • Stephan Mielke,
  • Martin Schreder,
  • Guido Kobbe,
  • Inken Hilgendorf and
  • Daniel Wolff
  • + 10 authors

15 February 2021

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELISp...

  • Article
  • Open Access
7,234 Views
13 Pages

30 April 2012

Acute graft-versus-host disease (aGVHD) remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Infections may coexist and in certain circumstances aggravate aGVHD. It was described that type 1...

  • Article
  • Open Access
12 Citations
9,001 Views
10 Pages

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis

  • Laura S. Sibley,
  • Andrew D. White,
  • Alice Marriott,
  • Michael J. Dennis,
  • Ann Williams,
  • Philip D. Marsh and
  • Sally A. Sharpe

13 March 2012

Tuberculosis is a global health problem. The Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine has variable efficacy (0–80%) so there is a drive to develop novel vaccines. The cytokine, interferon gamma (IFNγ), is an essential component of th...

  • Article
  • Open Access
1 Citations
2,425 Views
13 Pages

Validation of the Enzyme-Linked ImmunoSpot Analytic Method for the Detection of Human IFN-γ from Peripheral Blood Mononuclear Cells in Response to the SARS-CoV-2 Spike Protein

  • Laura E. Carreto-Binaghi,
  • Milton Nieto-Ponce,
  • Andrea Palencia-Reyes,
  • Rodolfo L. Chávez-Domínguez,
  • Jessica Blancas-Zaragoza,
  • Pablo Franco-Mendoza,
  • Montserrat A. García-Ramos,
  • Claudia I. Hernández-Lázaro,
  • Martha Torres and
  • Claudia Carranza

11 October 2024

COVID-19 vaccine evaluations are mainly focused on antibody analyses, but there is growing interest in measuring the cellular immune responses from the researchers evaluating these vaccines. The cellular responses to several COVID-19 vaccines have be...

  • Article
  • Open Access
15 Citations
9,822 Views
15 Pages

ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting

  • Alexey Y. Karulin,
  • Kinga Karacsony,
  • Wenji Zhang,
  • Oleg S. Targoni,
  • Ioana Moldovan,
  • Marcus Dittrich,
  • Srividya Sundararaman and
  • Paul V. Lehmann

20 January 2015

Each positive well in ELISPOT assays contains spots of variable sizes that can range from tens of micrometers up to a millimeter in diameter. Therefore, when it comes to counting these spots the decision on setting the lower and the upper spot size t...

  • Article
  • Open Access
29 Citations
6,482 Views
20 Pages

Identification of Promiscuous African Swine Fever Virus T-Cell Determinants Using a Multiple Technical Approach

  • Laia Bosch-Camós,
  • Elisabet López,
  • María Jesús Navas,
  • Sonia Pina-Pedrero,
  • Francesc Accensi,
  • Florencia Correa-Fiz,
  • Chankyu Park,
  • Montserrat Carrascal,
  • Javier Domínguez and
  • Fernando Rodríguez
  • + 3 authors

7 January 2021

The development of subunit vaccines against African swine fever (ASF) is mainly hindered by the lack of knowledge regarding the specific ASF virus (ASFV) antigens involved in protection. As a good example, the identity of ASFV-specific CD8+ T-cell de...

  • Article
  • Open Access
15 Citations
8,474 Views
15 Pages

Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses

  • Tomas Dillenbeck,
  • Eva Gelius,
  • Jenny Fohlstedt and
  • Niklas Ahlborg

27 November 2014

The involvement of T-helper (Th)1, Th17 and Th22 cell subsets, in immunity, as well as in pathological inflammatory reactions, makes it important to determine their relative proportion. A triple FluoroSpot detecting the hallmark cytokines of Th1 (IFN...

  • Article
  • Open Access
6 Citations
3,653 Views
11 Pages

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot

  • Laura Thümmler,
  • Sina Schwarzkopf,
  • Dietmar Knop,
  • J. Alexander Ross,
  • Victoria Berg,
  • Peter A. Horn and
  • Monika Lindemann

Herd immunity is essential to control severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), especially in immunocompromised patients. Convalescent individuals should be vaccinated later due to vaccine shortage, as studies show that neutr...

  • Article
  • Open Access
12 Citations
4,057 Views
14 Pages

14 September 2022

Previous reports demonstrated that FLU-v, a peptide-based broad-spectrum influenza vaccine candidate, induced antibody and cellular immune responses in humans. Here, we evaluate cellular effector functions and cross-reactivity. PBMC sampled pre- (day...

  • Communication
  • Open Access
28 Citations
4,536 Views
12 Pages

30 March 2022

In the present study, antibody and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines were compared 6 months after the two-dose immunization of healthy individuals. Additionally, antibody and T cell responses after the thir...

  • Article
  • Open Access
14 Citations
5,308 Views
38 Pages

Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study

  • Andrea M. Spiri,
  • Marilisa Novacco,
  • Marina L. Meli,
  • Martina Stirn,
  • Barbara Riond,
  • Jonathan E. Fogle,
  • Felicitas S. Boretti,
  • Imogen Herbert,
  • Margaret J. Hosie and
  • Regina Hofmann-Lehmann

31 August 2021

Feline calicivirus (FCV) is a common cat virus associated with oral ulcerations and virulent-systemic disease. Efficacious FCV vaccines protect against severe disease but not against infection. The high genetic diversity of FCV poses a challenge in v...

  • Article
  • Open Access
6 Citations
2,903 Views
15 Pages

Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies

  • Vassiliki C. Pitiriga,
  • Myrto Papamentzelopoulou,
  • Kanella E. Konstantinakou,
  • Irene V. Vasileiou,
  • Konstantina S. Sakellariou,
  • Natalia I. Spyrou and
  • Athanasios Tsakris

27 November 2023

Background: Immune response to SARS-CoV-2 is crucial for preventing reinfection or reducing disease severity. T-cells’ long-term protection, elicited either by COVID-19 vaccines or natural infection, has been extensively studied thus far; howev...

  • Article
  • Open Access
16 Citations
5,902 Views
16 Pages

Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons

  • Tomasz Stenzel,
  • Daria Dziewulska,
  • Bartłomiej Tykałowski,
  • Marcin Śmiałek,
  • Joanna Kowalczyk and
  • Andrzej Koncicki

31 October 2018

Pigeon circovirus (PiCV) is the most frequently diagnosed virus in pigeons and is thought to be one of the causative factors of a complex disease called the young pigeon disease syndrome (YPDS). The development of a vaccine against this virus could b...

  • Article
  • Open Access
7 Citations
2,541 Views
14 Pages

Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management

  • Guillem Safont,
  • Irene Latorre,
  • Raquel Villar-Hernández,
  • Zoran Stojanovic,
  • Alicia Marín,
  • Cristina Pérez-Cano,
  • Alicia Lacoma,
  • Bárbara Molina-Moya,
  • Alan Jhunior Solis and
  • José Domínguez
  • + 8 authors

30 August 2022

The measurement of specific T-cell responses can be a useful tool for COVID-19 diagnostics and clinical management. In this study, we evaluated the IFN-γ T-cell response against the main SARS-CoV-2 antigens (spike, nucleocapsid and membrane) in...

  • Article
  • Open Access
7 Citations
2,756 Views
12 Pages

IFN-γ-Based ELISpot as a New Tool to Detect Human Infections with Borna Disease Virus 1 (BoDV-1): A Pilot Study

  • Lisa Eidenschink,
  • Gertrud Knoll,
  • Dennis Tappe,
  • Robert Offner,
  • Thomas Drasch,
  • Yvonne Ehrl,
  • Bernhard Banas,
  • Miriam C Banas,
  • Hans Helmut Niller and
  • Markus Bauswein
  • + 9 authors

10 January 2023

More than 40 human infections with the zoonotic Borna disease virus 1 (BoDV-1) have been reported to German health authorities from endemic regions in southern and eastern Germany. Diagnosis of a confirmed case is based on the detection of BoDV-1 RNA...

  • Article
  • Open Access
16 Citations
3,526 Views
11 Pages

SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination

  • Vassiliki C. Pitiriga,
  • Myrto Papamentzelopoulou,
  • Kanella E. Konstantinakou,
  • Kalliopi Theodoridou,
  • Irene V. Vasileiou and
  • Athanasios Tsakris

30 June 2023

(1) Background: SARS-CoV-2 T cell immunity is rapidly activated following SARS-CoV-2 infection and vaccination and is crucial for controlling infection progression and severity. The aim of the present study was to compare the levels of T cell respons...

  • Article
  • Open Access
2 Citations
2,087 Views
14 Pages

Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers

  • Zsolt Matula,
  • Gabriella Bekő,
  • Viktória Király,
  • Márton Gönczi,
  • András Zóka,
  • András Baráth,
  • Ferenc Uher and
  • István Vályi-Nagy

19 December 2023

The effectiveness of COVID-19 vaccines developed against the original virus strain deteriorated noticeably in efficacy against the Omicron variant (B.1.1.529). Moreover, the immunity developed after vaccination or due to natural infection rapidly wan...

  • Article
  • Open Access
1,428 Views
15 Pages

Evaluation of T-Cell Responses Following Sequential Vaccination with PCV13 and PPSV23 Against Streptococcus pneumoniae in Patients with Psoriasis

  • Thea Wojtakowski,
  • Lukas van de Sand,
  • Lorena Helmer,
  • Mona Mokanis,
  • Oliver Witzke,
  • Peter A. Horn,
  • Adalbert Krawczyk,
  • Wiebke Sondermann and
  • Monika Lindemann

29 August 2025

Background: Characterization of cellular responses to vaccinations in immunocompromised patients remains an evolving area of research. This particularly applies for pneumococcal vaccination in diseases such as psoriasis and in the setting of immunosu...

  • Correction
  • Open Access
1 Citations
5,401 Views
2 Pages

Correction: Santos, R.S., et al. Improvement of IFNγ ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis. Cells 2015, 4, 1-18

  • Radleigh Santos,
  • Alcinette Buying,
  • Nazila Sabri,
  • John Yu,
  • Anthony Gringeri,
  • James Bender,
  • Sylvia Janetzki,
  • Clemencia Pinilla and
  • Valeria A. Judkowski

21 April 2015

The authors wish to make the following corrections to this paper [1]: [...]

  • Article
  • Open Access
14 Citations
4,820 Views
14 Pages

The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients

  • Monika Lindemann,
  • Johannes Korth,
  • Ming Sun,
  • Shilei Xu,
  • Christoph Struve,
  • Kai Werner,
  • Theresa Dornieden,
  • Peter A. Horn,
  • Oliver Witzke and
  • Benjamin Wilde

8 December 2018

In kidney transplant recipients, the cytomegalovirus (CMV) is frequently causing infection/reactivation and can trigger allograft rejection. To assess the risk of reactivation, the cellular immune response against CMV is increasingly assessed by cell...

  • Review
  • Open Access
60 Citations
13,835 Views
16 Pages

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials

  • Anatoli M. Malyguine,
  • Susan Strobl,
  • Kimberly Dunham,
  • Michael R. Shurin and
  • Thomas J. Sayers

10 May 2012

The profiling and monitoring of immune responses are key elements in the evaluation of the efficacy and development of new biotherapies, and a number of assays have been introduced for analyzing various immune parameters before, during, and after imm...

  • Article
  • Open Access
22 Citations
3,487 Views
15 Pages

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients

  • Smaranda Gliga,
  • Melanie Fiedler,
  • Theresa Dornieden,
  • Anne Achterfeld,
  • Andreas Paul,
  • Peter A. Horn,
  • Kerstin Herzer and
  • Monika Lindemann

25 January 2021

To estimate protection from cytomegalovirus (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially a...

  • Article
  • Open Access
1 Citations
2,118 Views
11 Pages

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

  • Dominique Bertrand,
  • Charlotte Laurent,
  • Mathilde Lemoine,
  • Ludivine Lebourg,
  • Mélanie Hanoy,
  • Frank Le Roy,
  • Dorian Nezam,
  • Diana Pruteanu,
  • Steven Grange and
  • Sophie Candon
  • + 3 authors

Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context. We assessed the T cell res...

  • Article
  • Open Access
2 Citations
7,367 Views
10 Pages

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

  • Stine Kiaer Larsen,
  • Morten Hansen,
  • Inge Marie Svane,
  • Per Thor Straten and
  • Mads Hald Andersen

26 April 2012

In recent years we and others have used the ELISPOT assay successfully to identify novel tumor antigens by the characterization of spontaneous HLA class I restricted immune responses against a number of minimal 9–10 amino acid long peptide epitopes....

  • Case Report
  • Open Access
12 Citations
6,250 Views
16 Pages

Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis

  • Jingge Zhao,
  • Beata Shiratori,
  • Haorile Chagan-Yasutan,
  • Makoto Matsumoto,
  • Toshiro Niki,
  • Michinori Tanaka,
  • Yayoi Takahashi,
  • Osumu Usami,
  • Yugo Ashino and
  • Toshio Hattori

In this study, we investigated the role of a matricellular protein galectin-9 (Gal-9) in pleural effusion related to tuberculosis (TB). Plasma and pleural fluid of a patient with extrapulmonary TB were analyzed for cytokine content by ELISA and Lumin...

  • Article
  • Open Access
19 Citations
8,634 Views
15 Pages

Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

  • Marika Nordberg,
  • Pia Forsberg,
  • Dag Nyman,
  • Barbro H. Skogman,
  • Clara Nyberg,
  • Jan Ernerudh,
  • Ingvar Eliasson and
  • Christina Ekerfelt

8 June 2012

The aim of this prospective study was to investigate the diagnostic performance of Borrelia (Bb)-induced interferon (IFN)-γ secretion detected by ELISPOT modified to be feasible for clinical laboratories as a supplementary test to the laboratory diag...

  • Article
  • Open Access
3 Citations
2,704 Views
13 Pages

T Cell Responses against Orthopoxviruses in HIV-Positive Patients

  • Sammet Stefanie,
  • Michael Koldehoff,
  • Pia Schenk-Westkamp,
  • Peter A. Horn,
  • Stefan Esser and
  • Monika Lindemann

27 January 2024

A global outbreak of predominantly sexually transmitted mpox infections, outside endemic regions, was reported in May 2022. Thereafter, risk groups were vaccinated against smallpox, a structurally related orthopoxvirus. In the current study, we analy...

  • Article
  • Open Access
21 Citations
15,284 Views
19 Pages

High Reproducibility of ELISPOT Counts from Nine Different Laboratories

  • Srividya Sundararaman,
  • Alexey Y. Karulin,
  • Tameem Ansari,
  • Nadine BenHamouda,
  • Judith Gottwein,
  • Sreenivas Laxmanan,
  • Steven M. Levine,
  • John T. Loffredo,
  • Stephanie McArdle and
  • Paul V. Lehmann
  • + 4 authors

9 January 2015

The primary goal of immune monitoring with ELISPOT is to measure the number of T cells, specific for any antigen, accurately and reproducibly between different laboratories. In ELISPOT assays, antigen-specific T cells secrete cytokines, forming spots...

  • Article
  • Open Access
1 Citations
1,770 Views
10 Pages

Assays for Assessing Mycobacterium avium Immunity and Evaluating the Effects of Therapeutics

  • Getahun Abate,
  • Krystal A. Meza,
  • Chase G. Colbert and
  • Christopher S. Eickhoff

15 October 2024

In Europe and North America, the prevalence of pulmonary nontuberculous mycobacteria (NTM) is increasing. Most pulmonary NTM infections are caused by the Mycobacterium avium complex (MAC). Sadly, the treatment of pulmonary MAC is suboptimal with fail...

  • Article
  • Open Access
2 Citations
4,583 Views
19 Pages

A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools

  • Meytal Dror Levinsky,
  • Baruch Brenner,
  • Michal Yalon,
  • Zohar Levi,
  • Zvi Livneh,
  • Zoya Cohen,
  • Tamar Paz-Elizur,
  • Rachel Grossman,
  • Zvi Ram and
  • Ilan Volovitz

17 January 2023

Personalized vaccines against patient-unique tumor-associated antigens represent a promising new approach for cancer immunotherapy. Vaccine efficacy is assessed by quantification of changes in the frequency and/or the activity of antigen-specific T c...

  • Article
  • Open Access
1 Citations
912 Views
13 Pages

Long-Term Follow-Up of T Cell Immunity Against Orthopoxviruses in People Living with HIV After Vaccination and Natural Monkeypox Virus Infection

  • Monika Lindemann,
  • Stefanie Sammet,
  • Felix Maischack,
  • Gabriela Graf,
  • Peter A. Horn,
  • Heidi Wiehler,
  • Jessica Wunderling and
  • Stefan Esser

13 September 2025

Background/Objectives: After the 2022 mpox outbreak also outside Africa, risk groups including people living with HIV (PLWH) were vaccinated with the Modified Vaccinia Ankara–Bavarian Nordic vaccine (MVA-BN). Previous data on PLWH showed that t...

  • Article
  • Open Access
1 Citations
1,392 Views
18 Pages

Cellular Immune Response in Horses After West Nile Neuroinvasive Disease

  • Csenge Tolnai,
  • Ciara O’Sullivan,
  • Márta Lőrincz,
  • Maria Karvouni,
  • Miklós Tenk,
  • András Marosi,
  • Petra Forgách,
  • Bettina Paszerbovics,
  • Zsombor Wagenhoffer and
  • Orsolya Kutasi

11 August 2025

West Nile virus (WNV) is a mosquito-borne neurotropic virus that causes neurologic disease in both humans and horses. Yet the long-term cellular immune response following natural infection in horses remains poorly understood. This study aims to evalu...

  • Article
  • Open Access
4,007 Views
11 Pages

Asian Flush Gene Variant Enhances Cellular Immunogenicity of COVID-19 Vaccine: Prospective Observation in the Japanese General Population

  • Sudarma Bogahawaththa,
  • Megumi Hara,
  • Takuma Furukawa,
  • Chiharu Iwasaka,
  • Takeshi Sawada,
  • Goki Yamada,
  • Mikiko Tokiya,
  • Kyoko Kitagawa,
  • Yasunobu Miyake and
  • Akiko Matsumoto
  • + 2 authors

5 September 2024

We previously reported a reduced humoral immune response to the COVID-19 vaccines. Subsequently, we observed a lower susceptibility to COVID-19 in individuals carrying the ALDH2 rs671 variant through a web-based retrospective survey. Based on these f...

  • Article
  • Open Access
40 Citations
6,773 Views
15 Pages

Predicted Peptides from Non-Structural Proteins of Porcine Reproductive and Respiratory Syndrome Virus Are Able to Induce IFN-γ and IL-10

  • Alexel Burgara-Estrella,
  • Ivan Díaz,
  • Irene M. Rodríguez-Gómez,
  • Sabine E. Essler,
  • Jesús Hernández and
  • Enric Mateu

11 February 2013

This work describes peptides from non-structural proteins (nsp) of porcine reproductive and respiratory syndrome virus (PRRSV) predicted as potential T cell epitopes by bioinfornatics and tested for their ability to induce IFN-γ and IL-10 responses....

  • Article
  • Open Access
2 Citations
3,038 Views
12 Pages

Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation

  • Monika Lindemann,
  • Benjamin Wilde,
  • Justa Friebus-Kardash,
  • Anja Gäckler,
  • Oliver Witzke,
  • Ulf Dittmer,
  • Peter A. Horn,
  • Andreas Kribben,
  • Nils Mülling and
  • Ute Eisenberger

16 September 2021

Chronic kidney disease may alter antiviral T cell immunity. In the current study, we assessed in 63 patients prior to kidney transplantation how humoral and cellular immunity against cytomegalovirus (CMV) correlated using an interferon (IFN)-γ ELISpo...

  • Article
  • Open Access
24 Citations
8,489 Views
16 Pages

2 March 2015

Accurate assessment of positive ELISPOT responses for low frequencies of antigen-specific T-cells is controversial. In particular, it is still unknown whether ELISPOT counts within replicate wells follow a theoretical distribution function, and thus...

  • Article
  • Open Access
25 Citations
6,851 Views
15 Pages

Immunological Roles of Elevated Plasma Levels of Matricellular Proteins in Japanese Patients with Pulmonary Tuberculosis

  • Beata Shiratori,
  • Jingge Zhao,
  • Masao Okumura,
  • Haorile Chagan-Yasutan,
  • Hideki Yanai,
  • Kazue Mizuno,
  • Takashi Yoshiyama,
  • Tadashi Idei,
  • Yugo Ashino and
  • Toshio Hattori
  • + 2 authors

Elevated matricellular proteins (MCPs), including osteopontin (OPN) and galectin-9 (Gal-9), were observed in the plasma of patients with Manila-type tuberculosis (TB) previously. Here, we quantified plasma OPN, Gal-9, and soluble CD44 (sCD44) by enzy...

  • Article
  • Open Access
14 Citations
4,245 Views
11 Pages

Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals

  • Ji-Young Hwang,
  • Yunhwa Kim,
  • Kyung-Min Lee,
  • Eun-Jeong Jang,
  • Chang-Hoon Woo,
  • Chang-Ui Hong,
  • Seok-Tae Choi,
  • Sivilay Xayaheuang,
  • Jong-Geol Jang and
  • Hosun Park
  • + 1 author

18 February 2022

In the face of a global COVID-19 vaccine shortage, an efficient vaccination strategy is required. Therefore, the immunogenicity of single or double COVID-19 vaccination doses (ChAdOX1, BNT162b2, or mRNA-1273) of SARS-CoV-2-recovered individuals was c...

  • Article
  • Open Access
7 Citations
10,035 Views
21 Pages

24 August 2012

Experimental allergic encephalomyelitis (EAE) is mediated by neuroantigen-specific pro-inflammatory T cells of the Th1 and Th17 effector class. Th-17 cells can be clearly defined by expression of IL-17, but not IFN-γ, IL-2 or IL-3. Th1 cells do not e...

  • Article
  • Open Access
6 Citations
3,111 Views
18 Pages

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma

  • Yibin Liu,
  • Anna Keib,
  • Brigitte Neuber,
  • Lei Wang,
  • Angelika B. Riemer,
  • Maria Bonsack,
  • Angela Hückelhoven-Krauss,
  • Anita Schmitt,
  • Carsten Müller-Tidow and
  • Michael Schmitt

18 January 2023

The transcription factor SOX11 is a tumor-associated antigen with low expression in normal cells, but overexpression in glioblastoma (GBM). So far, conventional surgery, chemotherapy, and radiotherapy have not substantially improved the dismal progno...

  • Article
  • Open Access
18 Citations
8,498 Views
18 Pages

A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip

  • Dieudonné R. Baganizi,
  • Loïc Leroy,
  • Loïc Laplatine,
  • Stacie J. Fairley,
  • Samuel Heidmann,
  • Samia Menad,
  • Thierry Livache,
  • Patrice N. Marche and
  • Yoann Roupioz

4 December 2015

The identification and characterization, at the cellular level, of cytokine productions present a high interest for both fundamental research and clinical studies. However, the majority of techniques currently available (ELISA, ELISpot, flow cytometr...

  • Article
  • Open Access
3 Citations
2,020 Views
13 Pages

Immunogenicity Analysis and Identification of Potential T-Cell Epitopes in C129R Protein of African Swine Fever Virus

  • Wenzhu Zhai,
  • Ying Huang,
  • Yuheng He,
  • Yuanyuan Chu,
  • Chunhao Tao,
  • Zhongbao Pang,
  • Zhen Wang,
  • Hongfei Zhu and
  • Hong Jia

The highly conserved C129R protein of AFSV was utilized in the development of an ASFV recombinant adenovirus vaccine, demonstrating strong immunogenicity. In this study, we immunized 6-week-old female C57BL/6J mice via subcutaneous injection with 10...

  • Article
  • Open Access
8 Citations
2,946 Views
14 Pages

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients

  • Laura Thümmler,
  • Michael Koldehoff,
  • Neslinur Fisenkci,
  • Leonie Brochhagen,
  • Peter A. Horn,
  • Adalbert Krawczyk and
  • Monika Lindemann

18 June 2022

Protecting vulnerable groups from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is mandatory. Immune responses after a third vaccination against SARS-CoV-2 are insufficiently studied in patients after hematopoietic stem-...

  • Article
  • Open Access
1,496 Views
21 Pages

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

  • Gerald K. Chege,
  • Rosamund E. Chapman,
  • Alana T. Keyser,
  • Craig H. Adams,
  • Kealan Benn,
  • Michiel T. van Diepen,
  • Nicola Douglass,
  • Bronwen Lambson,
  • Tandile Hermanus and
  • Anna-Lise Williamson
  • + 1 author

17 February 2025

We previously reported on HIV vaccines that elicited autologous Tier 2 neutralizing antibodies (nAbs) in rabbits. In the current study, we sought to establish a proof of concept that HIV vaccines using identical designs elicit Tier 2 nAbs in arhesus...

  • Article
  • Open Access
2 Citations
2,981 Views
17 Pages

11 July 2023

In this study, we demonstrate that expression of viral latent membrane protein 1 (LMP1) in a mouse B cell line renders the animals responsive to protection from a 38C13-LMP1 tumor challenge with a novel vaccine. The Epstein–Barr virus (EBV) pre...

  • Article
  • Open Access
5 Citations
3,609 Views
14 Pages

Characterization of Conserved and Promiscuous Human Rhinovirus CD4 T Cell Epitopes

  • Marta Gomez-Perosanz,
  • Tara Fiyouzi,
  • Miguel Fernandez-Arquero,
  • John Sidney,
  • Alessandro Sette,
  • Ellis L. Reinherz,
  • Esther M. Lafuente and
  • Pedro A. Reche

2 September 2021

Human rhinovirus (RV) is the most common cause of upper respiratory infections and exacerbations of asthma. In this work, we selected 14 peptides (6 from RV A and 8 from RV C) encompassing potential CD4 T cell epitopes. Peptides were selected for bei...

  • Article
  • Open Access
4 Citations
4,989 Views
16 Pages

Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice

  • Shuenn-Jue Wu,
  • Dan Ewing,
  • Appavu K. Sundaram,
  • Hua-Wei Chen,
  • Zhaodong Liang,
  • Ying Cheng,
  • Vihasi Jani,
  • Peifang Sun,
  • Gregory D. Gromowski and
  • Maya Williams
  • + 4 authors

Dengue fever, caused by any of four dengue viruses (DENV1-4), is a major global burden. Currently, there is no effective vaccine that prevents infection in dengue naïve populations. We tested the ability of two novel adjuvants (Advax-PEI and Adv...

  • Article
  • Open Access
2,777 Views
20 Pages

T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac

  • Sergey Petrovich Krechetov,
  • Valentina Valentinovna Vtorushina,
  • Evgenia Vladimirovna Inviyaeva,
  • Elena Aleksandrovna Gorodnova,
  • Svetlana Vladimirovna Kolesnik,
  • Dmitry Anatolievich Kudlay,
  • Pavel Igorevich Borovikov,
  • Liubov Valentinovna Krechetova,
  • Nataliya Vitalievna Dolgushina and
  • Gennady Tikhonovich Sukhikh

18 January 2023

The COVID-19 pandemic has required extensive research on the new coronavirus SARS-CoV-2 and the creation of new highly effective vaccines. The presence of T-cells in the body that respond to virus antigens suggests adequate antiviral immunity. We inv...

of 3